Dr. Arozullah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Astellas Way
Astellas Pharma Global Development
Northbrook, IL 60062Phone+1 224-205-5535Fax+1 224-205-5917- Is this information wrong?
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1992 - 1995
- Northwestern University The Feinberg School of MedicineClass of 1992
Certifications & Licensure
- IL State Medical License 1995 - 2026
Publications & Presentations
PubMed
- 45 citationsZolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial.Manish A Shah, Kohei Shitara, Jaffer A Ajani, Yung-Jue Bang, Peter Enzinger, David Ilson, Florian Lordick, Eric Van Cutsem, Javier Gallego Plazas, Jing Huang, Lin Shen...> ;Nature Medicine. 2023 Aug 1
- 3 citationsILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma.Samuel J Klempner, Keun-Wook Lee, Kohei Shitara, Jean-Phillippe Metges, Sara Lonardi, David H Ilson, Nicola Fazio, Tae Yong Kim, Li-Yuan Bai, Diarmuid Moran, Jianning ...> ;Clinical Cancer Research. 2023 Oct 2
- 58 citationsZolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junc...Kohei Shitara, Florian Lordick, Yung-Jue Bang, Peter Enzinger, David Ilson, Manish A Shah, Eric Van Cutsem, Rui-Hua Xu, Giuseppe Aprile, Jianming Xu, Joseph Chao, Robe...> ;Lancet. 2023 May 20
- Join now to see all
Press Mentions
- First ADC/Immuno-Oncology Combination Approved for Urothelial CancerApril 4th, 2023
- After Rumored Merger Fell Through, Merck and Seagen's Padcev-Keytruda Combo Wins Bladder Cancer NodApril 3rd, 2023
- Zolbetuximab Improves Survival in Gastric CancerMarch 26th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: